Macquarie Group LTD Smith & Nephew PLC Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$24.33 - $31.28 $267 - $344	-11 Reduced 4.82%	217 $5,000
Q1 2022 May 16, 2022	SELL	$30.84 - $36.38 $616 - $727	-20 Reduced 8.06%	228 $7,000
Q4 2021 Feb 11, 2022	BUY	$31.98 - $37.15 $671 - $780	21 Added 9.25%	248 $9,000
Q3 2021 Nov 12, 2021	BUY	$34.34 - $44.17 $3,056 - $3,931	89 Added 64.49%	227 $8,000
Q2 2021 Aug 13, 2021	BUY	$37.86 - $44.01 $1,249 - $1,452	33 Added 31.43%	138 $6,000
Q1 2021 May 14, 2021	BUY	$36.75 - $45.88 $3,858 - $4,817	105 New	105 $4,000

221

30.2M

900

6.6K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $11B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.